US$ 25.10
retatrutide news today recency 3 Today, we shared new data from the latest Phase study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more People Are Already Taking This
Description
Diabetes 54, 26852693

The theoretical concerns centre on the potential for these large peptide molecules to affect infant growth, glucose metabolism, or gastrointestinal function, though the extent of oral bioavailability following ingestion in breast milk is uncertain

The medication comes from licensed 503A compounding pharmacies, meets pharmaceutical standards, and is available across all 50 states, offering flexibility that brand-name Ozempic cannot
As such, only a healthcare provider can prescribe Glp-1s
We just dont know how well it works because it hasnt been studied, says V
